News

OxyCon 2025 to Focus on AI's Role in Web Scraping Insights

OxyCon 2025 to Focus on AI's Role in Web Scraping Insights

Exciting Developments at OxyCon 2025

OxyCon 2025 has announced its remarkable speaker lineup, highlighting the significance of AI and web scraping in today's data-driven world. Oxylabs, a leading web intelligence platform, is set to host this influential online event that promises to attract professionals from various industries.

A Day of Industry Insights

The event will spotlight conversations among experts from prominent organizations such as Turing, NielsenIQ, and TEGOS Legal. Oxylabs is collaborating with these industry leaders to create an engaging and informative experience centered around the theme of AI in web intelligence.

Exploring the Role of AI

This year's conference theme revolves around understanding how AI influences web scraping and intelligence. Attendees can expect sessions that delve into the legal frameworks surrounding data use, actionable insights for developers, and the far-reaching implications of AI across industries. The combination of these topics aims to foster a collaborative atmosphere among all participants.

What to Expect from the Speaker Line-Up

The agenda for this year's OxyCon will feature discussions led by influential figures in the field. Zia Ahmad, a Data Scientist at Turing, will present innovative machine learning applications that enhance web scraping practices. He will share real-life examples from his work with Google's Gemini project, providing valuable insights into how technology is evolving in this space.

Innovations in E-Commerce Data

Fred de Villamil, CTO at NielsenIQ Digital Shelf, will highlight how e-commerce can scale data extraction, enabling organizations to manage extensive product data efficiently. His expertise in this area will help attendees grasp the importance of not only obtaining data but also making sense of it as a key to operational success.

Legal Insights and AI

Denas Grybauskas, Chief Governance and Strategy Officer at Oxylabs, will lead a panel discussing the complex legal landscape of AI and web scraping. With contributions from partners in the Ethical Web Data Collection Initiative, this session will cover the ethical responsibilities associated with data usage.

Building AI Tools with Ease

A hands-on workshop hosted by Rytis Ulys, Head of Data & Analytics at Oxylabs, will guide attendees through creating AI-powered price comparison tools using their proprietary technologies. This practical session aims to equip participants with the necessary skills to stay ahead in this rapidly evolving tech landscape.

The Interconnectedness of AI and Web Scraping

Zia Ahmad emphasizes the symbiotic relationship between AI and web scraping. He explains how data extracted from the web can feed AI models, which in turn can improve scraping techniques. This fascinating feedback loop is central to the ongoing transformation in how data is collected and analyzed.

Join OxyCon 2025

People interested in participating in this transformative experience can secure their free spots for the event scheduled for October 1st. The virtual format allows attendees from around the globe to connect, learn, and engage with peers and experts.

Additionally, Oxylabs encourages participants to join the OxyCon Discord community, where ongoing discussions and networking opportunities will be available before, during, and after the event. This interactive platform ensures that all participants stay engaged and informed about emerging trends in web intelligence.

About Oxylabs

Established in 2015, Oxylabs stands as a preeminent provider of web intelligence solutions and proxy services. Their commitment to innovation and ethical practices has positioned them as a leader in the industry, trusted by numerous Fortune Global 500 companies. Recognized for their rapid growth, Oxylabs continues to set standards in data collection and analysis.

Frequently Asked Questions

What is OxyCon 2025 about?

OxyCon 2025 focuses on the role of AI in web scraping, bringing together industry experts to share insights and discussions on the latest developments.

Who can attend OxyCon 2025?

The event is open to anyone interested in AI and web scraping, with free registration available for participants across the globe.

What topics will be covered at the event?

Topics will include machine learning applications for web scraping, legal implications, data extraction techniques, and building AI tools.

Who are the featured speakers?

Featured speakers include representatives from organizations such as Turing, NielsenIQ, and Oxylabs, sharing their expertise in various related fields.

How can I participate in discussions during the event?

Attendees can join the OxyCon Discord community, allowing them to engage directly with speakers and fellow participants before, during, and after the sessions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 501

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 18

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 78

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Initiated for Voyager Therapeutics Investors

Updated Category News Views 115

Investigation Overview for Voyager Therapeutics Investors Pomerantz LLP is currently exploring possible claims on behalf of investors in Voyager Therapeutics, Inc. (NASDAQ: VYGR). This exploration arises from concerns surrounding the company’s recent announcements and operational strategies. Details of the Investigation The inquiry focuses on whether Voyager and some of...

Continue Reading
Subway's Creative Middle Seat Reward for Travelers

Updated Category News Views 132

Subway Announces Exciting Promotion for Air Travelers On January 27, a significant change is happening for travelers, especially for those who dread sitting in the middle seat of a plane. With a popular airline ending its open seating policy, millions are gearing up for assigned seating. This means that many passengers might find themselves in the middle seat, which is...

Continue Reading
Expanse Studios Unveils Innovative Games at Major Summit

Updated Category News Views 86

Expanse Studios Shines at Industry Summit Expanse Studios, a cutting-edge gaming developer and a subsidiary of Golden Matrix Group Inc. (NASDAQ: GMGI), has made a significant impression at the recent SBC Summit Lisbon. This event attracted around 25,000 attendees, featuring a mix of gaming innovators and industry experts, all eager to explore what's next in the gaming...

Continue Reading
Unlocking Digital Preservation Skills Through New Academy

Updated Category News Views 150

Introducing the Preservica Academy for Digital Preservation Preservica Inc. has unveiled its exciting new initiative, Preservica Academy, dedicated to enhancing the skills of professionals and beginners in the realm of digital preservation. This innovative program focuses on Active Digital Preservation™, aiming to ensure the long-term accessibility and integrity of...

Continue Reading
Seritage Growth Properties Investors Alert: Class Action Lawsuit Update

Updated Category News Views 107

Notification of Class Action Lawsuit for Seritage Growth Properties Levi & Korsinsky, LLP is reaching out to inform investors of Seritage Growth Properties (NYSE: SRG) regarding an ongoing class action securities lawsuit. This case marks an important development for those affected by alleged securities fraud. Overview of the Class Action Lawsuit This lawsuit is centered...

Continue Reading